Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
grade B 2.05 -9.69% -0.22
ACST closed up 5.58 percent on Tuesday, November 19, 2019, on 3.47 times normal volume.
11 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ACST trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup -9.69%
Volume Surge Other -9.69%
Above Upper BB Strength -9.69%
Up 3 Days in a Row Strength -9.69%
Upper Bollinger Band Touch Strength -9.69%
Pocket Pivot Bullish Swing Setup -4.65%
Volume Surge Other -4.65%
Calm After Storm Range Contraction -4.65%
Upper Bollinger Band Touch Strength -4.65%
Crossed Above 20 DMA Bullish 0.49%

Older signals for ACST ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
ACST Chart by TradingView
Basic chart:
Profile
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Medicine Chemistry Biopharmaceutical Health Cardiovascular Disease Lipid Cardiovascular Disorders Fatty Acids Hypertriglyceridemia Omega 3 Fatty Acid
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 20 33 Stocks Moving in Wednesday's Pre-Market Session
Nov 19 Amarin slips 3% on bearish coverage
Nov 18 Piper likes DexCom in premarket analyst action
Nov 18 Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in Diabetes
Nov 15 AMAT, JCP among premarket gainers
Nov 14 Acasti, Matinas rise on Amarin heart drug news
Nov 14 Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q2 2020 Results - Earnings Call Transcript
Nov 13 Acasti Pharma +5% premarket on Q2 results
Nov 13 Acasti Pharma EPS misses by $0.22
Nov 13 Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
See more ACST news...
Indicators
Indicator Value
52 Week High 2.95
52 Week Low 0.6
Average Volume 1,150,625
200-Day Moving Average 1.4537
50-Day Moving Average 2.0194
20-Day Moving Average 1.9765
10-Day Moving Average 2.03
Average True Range 0.152
ADX 17.52
+DI 27.0979
-DI 14.7666
Chandelier Exit (Long, 3 ATRs ) 1.814
Chandelier Exit (Short, 3 ATRs ) 2.2374
Upper Bollinger Band 2.2173
Lower Bollinger Band 1.7357
Percent B (%b) 1.11
BandWidth 24.366304
MACD Line 0.0351
MACD Signal Line 0.0049
MACD Histogram 0.0302
Fundamentals Value
Market Cap 33.4 Million
Num Shares 14.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -2.95
Price-to-Sales 0.00
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.48
Resistance 3 (R3) 2.46 2.36 2.45
Resistance 2 (R2) 2.36 2.31 2.38 2.43
Resistance 1 (R1) 2.32 2.28 2.34 2.34 2.42
Pivot Point 2.22 2.22 2.24 2.24 2.22
Support 1 (S1) 2.18 2.17 2.20 2.20 2.12
Support 2 (S2) 2.08 2.14 2.10 2.11
Support 3 (S3) 2.04 2.08 2.10
Support 4 (S4) 2.06